Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM-CBQV for Prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 57 adverse event reports in the FDA FAERS database where PEGFILGRASTIM-CBQV was used for Prophylaxis.

Most Reported Side Effects for PEGFILGRASTIM-CBQV

Side Effect Reports % Deaths Hosp.
Device malfunction 356 48.6% 1 3
No adverse event 265 36.2% 0 0
Death 76 10.4% 76 4
Product dose omission issue 61 8.3% 3 5
Product label confusion 36 4.9% 0 1
Accidental exposure to product 29 4.0% 0 0
Neutrophil count decreased 18 2.5% 0 9
Bone pain 17 2.3% 0 2
Device failure 16 2.2% 0 1
Product packaging confusion 16 2.2% 0 0
Product quality issue 15 2.1% 0 1
Hospitalisation 14 1.9% 1 13
Device leakage 13 1.8% 0 0
Febrile neutropenia 13 1.8% 0 12
Drug ineffective 12 1.6% 0 6

Other Indications for PEGFILGRASTIM-CBQV

Product used for unknown indication (409) Infection prophylaxis (62) Neutropenia (19) Pancreatic carcinoma (12) Agranulocytosis (8) Breast cancer (8) Chemotherapy (8) Febrile neutropenia (8) Breast cancer female (6) Bone cancer (5)

Other Drugs Used for Prophylaxis

PEGFILGRASTIM (7,424) HUMAN C1-ESTERASE INHIBITOR (5,950) DENOSUMAB (4,541) SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197) ASPIRIN (2,083) VALACYCLOVIR (1,574) PANTOPRAZOLE (1,502) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444) CLOPIDOGREL BISULFATE (1,296) ENOXAPARIN (1,278)

Related Pages

PEGFILGRASTIM-CBQV Full Profile All Prophylaxis Drugs PEGFILGRASTIM-CBQV Demographics PEGFILGRASTIM-CBQV Timeline